Pro-C3 in combination with clinical parameters is associated with severity of histological features of non-alcoholic steatohepatitis and fibrosis

被引：0
|
作者：
Leeming, Diana J. [1 ]
Nielsen, Mette J. [1 ]
Goodman, Zachary D. [2 ]
Friedman, Scott L. [3 ]
Lefebvre, Eric [4 ]
Seyedka-Zemi, Star [4 ]
Wiens, Brian [4 ]
Fischer, Laurent [4 ]
Karsdal, Morten A. [1 ]
Sanyal, Arun J. [5 ]
Ratziu, Vlad [6 ,7 ]
机构：
[1] Nord Biosci Biomarkers & Res AS, Herlev, Denmark
[2] Inova Fairfax Hosp, Ctr Liver Dis, Falls Church, VA USA
[3] Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY 10029 USA
[4] Allergan Plc, San Francisco, CA USA
[5] Virginia Commonwealth Univ, Dept Gastroenterol, Richmond, VA USA
[6] Hop La Pitie Salpetriere, Paris, France
[7] Univ Paris 06, Paris, France
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2101
引用
收藏
页码：1107A / 1108A
页数：2
相关论文
共 50 条
  • [1] Improvement of fibrosis is associated with the decrease of collagen III formation biomarker Pro-C3 in patients with non-alcoholic steatohepatitis
    Luo, Yi
    Vincent, Robert
    Gagnon, Robert C.
    Charles, Edgar D.
    Oseini, Abdul
    Mirshahi, Faridoddin
    Banini, Bubu A.
    Daita, Kalyani
    Idowu, Michael O.
    Rosen, Glenn D.
    Jarai, Gabor
    Christian, Rose
    Sanyal, Arun J.
    HEPATOLOGY, 2017, 66 : 345A - 345A
  • [2] Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients
    Singh, Deepak Kumar
    Rastogi, Archana
    Sakhuja, Puja
    Gondal, Ranjana
    Sarin, Shiv Kumar
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2010, 53 (03) : 408 - 413
  • [3] Clinical and pathological features of non-alcoholic steatohepatitis
    Nonomura, A
    Enomoto, Y
    Takeda, M
    Tamura, T
    Kasai, T
    Yoshikawa, T
    Nakamine, H
    Kojima, H
    Uemura, M
    Zen, Y
    Minato, H
    HEPATOLOGY RESEARCH, 2005, 33 (02) : 116 - 121
  • [4] BMS-986036, a PEGylated fibroblast growth factor 21 analogue, reduces fibrosis and Pro-C3 in a mouse model of non-alcoholic steatohepatitis
    Luo, Y.
    Krupinski, J.
    Gao, S.
    Charles, E.
    Christian, R.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S396 - S397
  • [5] ASSOCIATIONS OF ENHANCED LIVER FIBROSIS (ELF) AND PRO-C3 WITH STAGE OF FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Felix, Sean
    Lam, Brian P.
    Jeffers, Thomas
    Goodman, Zachary D.
    Stepanova, Maria
    Younossi, Zobair M.
    HEPATOLOGY, 2021, 74 : 803A - 804A
  • [6] Serum Pro-C3 combined with clinical parameters is superior to established serological fibrosis tests at identifying patients with advanced fibrosis among patients with non-alcoholic fatty liver disease
    Daniels, S. J.
    Nielsen, M. J.
    Krag, A.
    Eslam, M.
    Karsdal, M. A.
    Leeming, D. J.
    George, J.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S671 - S671
  • [7] Correlation of serum leptin levels with clinical and histological parameters in patients of non-alcoholic steatohepatitis
    Sakhuja, Puja
    Kumar, Deepak
    Malhotra, Veena
    Gondal, Ranjana
    Sarin, Shiv Kumar
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A151 - A151
  • [8] Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis
    Marques Souza de Oliveira, Claudia Pinto
    Stefano, Jose Tadeu
    Forte de Siqueira, Erika Rabelo
    Silva, Leonardo Soares
    de Campos Mazo, Daniel Ferraz
    Rodrigues Lima, Vicencia Mara
    Furuya, Carlos Kioshi
    Mello, Evandro Sobroza
    Souza, Fabricio G.
    Rabello, Fabiola
    Santos, Telma Eugenio
    Nogueira, Monize Aydar
    Caldwell, Stephen H.
    Ferreira Alves, Venancio Avancini
    Carrilho, Flair Jose
    HEPATOLOGY RESEARCH, 2008, 38 (02) : 159 - 165
  • [9] Estimation of serum "true collagen type III formation" (Pro-C3) levels as a marker of non-alcoholic steatohepatitis in a prospective cohort
    Leeming, D. J.
    Grove, J. I.
    Kaye, P.
    Hoad, C.
    Francis, S.
    Nielsen, M. J.
    Karsdal, M. A.
    Guha, I. N.
    Aithal, G. P.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S154 - S154
  • [10] Clinical features commonly associated with fatty liver non-alcoholic steatohepatitis (NASH).
    Badalamenti, S
    Kligerman, S
    Molina, E
    Jeffers, L
    Reddy, R
    Schiff, E
    HEPATOLOGY, 1998, 28 (04) : 385A - 385A
12345